Thrombotic microangiopathy associated with use of interferon-beta

Interferon-beta is widely used for the treatment of relapsing multiple sclerosis. The drug is usually well tolerated, but autoimmune adverse effects, including kidney disease, have been reported. Only a few cases of hemolytic uremic syndrome-thrombotic microangiopathy associated interferon-alpha hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Olea, Teresa, Díaz-Mancebo, Raquel, Picazo, Maria-Luz, Martínez-Ara, Jorge, Robles, Angel, Selgas, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399315/
https://www.ncbi.nlm.nih.gov/pubmed/22815645
http://dx.doi.org/10.2147/IJNRD.S30194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399315/
https://www.ncbi.nlm.nih.gov/pubmed/22815645
http://dx.doi.org/10.2147/IJNRD.S30194

Ejemplares similares